Is Vaishali Pharma Ltd (VAISHALI) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vaishali Pharma Ltd is a average quality company .

Is Vaishali Pharma Ltd (VAISHALI) undervalued or overvalued?

The key valuation ratios of Vaishali Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Vaishali Pharma Ltd (VAISHALI) share price return in the past 10 years?

Data is not available for this company

Is Vaishali Pharma Ltd (VAISHALI) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vaishali Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Vaishali Pharma Ltd (VAISHALI)?

Company share prices are keep on changing according to the market conditions. The current trading price of Vaishali Pharma Ltd (VAISHALI) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Vaishali Pharma?

The latest standalone P/E ratio of Vaishali Pharma as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Vaishali Pharma Ltd (VAISHALI)?

The latest standalone P/B ratio of Vaishali Pharma Ltd (VAISHALI) as of 01-Jan-1970 is 1.23.

What is the 52-week high and low of Vaishali Pharma Ltd (VAISHALI)?

The 52-week high of Vaishali Pharma Ltd (VAISHALI) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Vaishali Pharma Ltd (VAISHALI) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Vaishali Pharma Ltd (VAISHALI)
Brand: Vaishali Pharma

Vaishali Pharma Ltd (VAISHALI) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 NSE: VAISHALI | Trading | Small Cap

Key Metrics

Market Cap

₹85 Cr.

P/E Ratio

0.00

Price to Book (P/B)

1.23

Price to Sales (P/S)

0.75

EV/EBITDA

53.25

Return on Capital Employed (ROCE)

4.99%

Current Price

₹0

Return on Equity (ROE)

1.62%

Return on Assets (ROA)

0.86%

Operating Profit Margin

0.6%

Net Profit Margin

0.83%

Gross Profit Margin

1.7%

Book Value per Share

₹5.3

Sales Growth (YoY)

14.78%

Sales Growth (3 Years)

9.31%

Operating Profit Growth (1 Year)

-65.87%

Operating Profit Growth (3 Years)

-56.43%

Net Profit Growth (1 Year)

13.89%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

-41.21%

Dividend Yield

0.00%

Promoter Holding

31.61%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Vaishali Pharma Ltd?

Vaishali Pharma Ltd revenue growth is 14.8% for FY-2025 , which is above its 5 year CAGR of 10.5% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Vaishali Pharma Ltd?

Promoters hold 31.61% of the Vaishali Pharma Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Vaishali Pharma Ltd vs industry peers?

Vaishali Pharma Ltd revenue CAGR is 10.51% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Vaishali Pharma Ltd belong to?

Vaishali Pharma Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Vaishali Pharma Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.

DeciZen - make an informed investing decision on Vaishali Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Vaishali Pharma stock performance

Key Ratios

Is Vaishali Pharma Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	12.8%	16.2%	12.8%	9.8%	6.9%	10.3%	18.9%	21.9%	5.8%	5%	-
Value Creation Index ⓘ	-0.1	0.2	-0.1	-0.3	-0.5	-0.3	0.4	0.6	-0.6	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	66.7	64	67.8	75.1	60.1	53.8	75.8	69.7	86.3	99	113
Sales YoY Gr.	-	-4.1%	5.9%	10.8%	-20%	-10.5%	41%	-8.1%	23.9%	14.8%	-
Adj EPS ⓘ	-0	0	0.1	0	-0.1	0.1	0.4	0.6	0.1	0.1	-0
YoY Gr.	-	NA	250%	-71.4%	-350%	NA	400%	68.6%	-89.8%	-16.7%	-
BVPS (₹) ⓘ	0.7	0.1	2	2	2	2.1	2.5	3.1	3.3	5	5.3
Adj Net Profit ⓘ	-0.1	0.7	0.7	0.2	-0.6	0.8	3.7	6.2	0.6	0.6	-1
Cash Flow from Ops. ⓘ	4.6	0.5	-9.5	4.3	3.2	2	1.3	1.1	0.8	-18	-
Debt/CF from Ops. ⓘ	4.6	49.6	-1.9	4	5.2	8.7	15.8	12.7	15.6	-0.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.5%	10.5%	9.3%	14.8%
Adj EPS ⓘ	NA	NA	-47.7%	-16.7%
BVPSⓘ	25%	19.7%	25.8%	49.1%
Share Price	-	-27.6%	-64.4%	-46.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-1.5	19.8	5.6	1	-2.7	3.5	15.2	18.6	1.4	1.1	-0.8
Op. Profit Mgn % ⓘ	0.8	5.4	4.1	2.8	1.5	4.9	9.1	13.5	1.9	0.6	-1.5
Net Profit Mgn % ⓘ	-0.1	1.1	1	0.3	-1	1.4	4.9	8.9	0.7	0.6	-0.5
Debt to Equity ⓘ	6.6	5.8	0.9	0.8	0.8	0.8	0.8	0.4	0.4	0.2	-
Working Cap Days ⓘ	244	255	283	312	396	501	390	400	318	333	149
Cash Conv. Cycle ⓘ	104	107	122	115	137	152	122	168	135	98	89

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	113	-
BVPS (₹) ⓘ	5.3	-
Reserves (₹ Cr.) ⓘ	43	-
P/BV ⓘ	1.23	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	84.7
Equity (₹ Cr.)	26.1
Face Value (₹)	2
Industry PE ⓘ	24.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vaishali Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	66.71	63.97	67.76	75.09	60.09	53.77	75.82	69.66	86.28	99.03
Operating Expenses ⓘ +	66.16	60.50	64.97	73.01	59.18	51.13	68.94	60.28	84.61	98.45
Manufacturing Costs	0	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.04
Material Costs	62.03	56.14	59.90	68.66	51.09	46.15	63.50	54.68	74.42	85.67
Employee Cost	1.56	1.59	2.04	2.13	1.27	1.19	1.36	1.30	1.40	1.58
Other Costs ⓘ	2.57	2.74	3	2.19	6.80	3.77	4.06	4.28	8.77	11.16
Operating Profit ⓘ	0.55	3.47	2.79	2.08	0.90	2.65	6.89	9.38	1.67	0.57
Operating Profit Margin (%)	0.8%	5.4%	4.1%	2.8%	1.5%	4.9%	9.1%	13.5%	1.9%	0.6%
Other Income ⓘ +	3.18	0.93	1.66	1.98	2.17	1.81	1.79	2.23	2.03	3.21
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	3.37	3.10	2.85	2.66	2.56	2.63	2.49	2.26	2.27	2.07
Depreciation ⓘ	0.37	0.28	0.25	0.27	0.44	0.43	0.46	0.50	0.51	0.49
Profit Before Tax ⓘ	-0	1.03	1.35	1.13	0.08	1.40	5.73	8.85	0.93	1.23
Tax ⓘ	0.03	0.32	0.55	0.42	0.05	0.36	1.70	2.24	0.21	0.41
Profit After Tax	-0.03	0.71	0.80	0.71	0.03	1.05	4.02	6.60	0.72	0.82
PAT Margin (%)	-0.1%	1.1%	1.2%	1.0%	0.1%	2.0%	5.3%	9.5%	0.8%	0.8%
Adjusted EPS (₹)	-0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3.20	3.97	20.60	21.40	21.38	22.42	26.35	32.97	35.81	64.92
Share Capital ⓘ	0.50	3	6.59	6.59	10.55	10.55	10.55	10.55	10.72	26.09
Reserves ⓘ	2.70	0.97	14.01	14.81	10.84	11.87	15.81	22.43	25.10	38.82
Debt +	19.76	21.12	17.56	16.23	15.68	15.66	19.80	12.57	11.22	8.50
Long Term Debt	4.48	3.37	2.65	4.78	4.05	4.03	3.11	5.23	3.60	4.20
Short Term Debt	15.29	17.75	14.91	11.45	11.63	11.62	16.69	7.34	7.62	4.30
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	24.66	15.38	22.38	24.53	23.63	40.54	28.38	18	19.39	27.14
Others Liabilities ⓘ	1.78	4.26	3.56	6.49	5.39	7.37	6.93	15.22	13.36	9.10
Total Liabilities ⓘ	49.40	44.73	64.10	68.64	66.08	85.98	81.46	78.75	79.78	109.66
Fixed Assets
Net Fixed Assets ⓘ +	1.40	1.29	1.26	1.34	1.49	1.22	1.18	1.98	1.52	1.83
Gross Block	2.51	1.57	1.79	2.14	2.73	2.89	3.30	3.85	3.89	4.69
Accumulated Depreciation	1.11	0.28	0.53	0.80	1.24	1.67	2.12	1.86	2.37	2.86
CWIP ⓘ	0	0	0.08	0.04	0.08	0.05	0.49	0.67	0.74	0.25
Investments ⓘ	0.38	0.38	0.43	0.43	0.43	0.43	0.43	0.43	0.43	0.43
Inventories	3.36	1.15	1.87	0.98	0.88	0.59	0.63	3.05	0.38	4.81
Trade Receivables	40.42	37.47	44.58	49.42	47.03	66.73	58.51	53.61	49.43	46.72
Cash Equivalents	1.05	0.18	0.28	0.32	0.38	0.47	1.36	0.98	1.58	1.84
Others Assets ⓘ	2.81	4.26	15.59	16.12	15.80	16.50	18.87	18.02	25.71	53.78
Total Assets ⓘ	49.40	44.73	64.10	68.64	66.08	85.98	81.46	78.75	79.78	109.66

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4.59	0.46	-9.46	4.31	3.22	2.01	1.32	1.08	0.81	-18.04
PBT ⓘ	-0	1.03	1.35	1.13	0.08	1.40	5.73	8.85	0.93	1.23
Adjustment ⓘ	0.55	2.45	1.61	1.66	5.78	3.45	1.62	1.16	5.85	6.91
Changes in Working Capital ⓘ	4.08	-2.95	-12.04	1.62	-1.91	-2.78	-5.2	-7.36	-3.7	-25.82
Tax Paid ⓘ	-0.04	-0.08	-0.37	-0.10	-0.72	-0.06	-0.83	-1.56	-2.28	-0.35
Cash Flow From Investing Activity ⓘ +	3.07	0.69	1.06	-0.28	-0.02	-0.11	-0.85	0.28	1.20	-0.19
Capex	-0.08	-0	-0.31	-0.30	-0.05	-0.13	-0.86	-0.30	-0.11	-0.30
Net Investments	0	0	-0.06	0	0	0	0	0	0	0
Others ⓘ	3.16	0.70	1.43	0.01	0.03	0.02	0.02	0.58	1.31	0.12
Cash Flow From Financing Activity ⓘ +	-7.62	-1.20	8.50	-3.99	-3.14	-1.81	0.42	-1.73	-1.42	18.49
Net Proceeds from Shares ⓘ	0	0	15.79	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-3.74	2.42	-1.63	2.14	-0.61	0.94	-1.88	2.25	-1.33	0.60
Interest Paid ⓘ	-3.37	-3.08	-2.82	-2.67	-2.53	-2.62	-2.44	-1.89	-1.74	-1.50
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.52	-0.54	-2.84	-3.46	0.01	-0.13	4.74	-2.10	1.65	19.39
Net Cash Flow ⓘ	0.04	-0.05	0.10	0.04	0.06	0.09	0.89	-0.37	0.59	0.26

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-0.94	19.8	6.49	3.4	0.15	4.78	16.5	22.26	2.09	1.62
ROCE (%)	12.8	16.18	12.75	9.8	6.89	10.33	18.87	21.92	5.82	4.99
Asset Turnover Ratio	1.4	1.36	1.25	1.13	0.89	0.71	0.91	0.87	1.09	1.05
PAT to CFO Conversion(x)	N/A	0.65	-11.83	6.07	107.33	1.91	0.33	0.16	1.13	-22
Working Capital Days
Receivable Days	205	222	221	228	293	386	301	294	218	177
Inventory Days	18	13	8	7	6	5	3	10	7	10
Payable Days	123	130	115	125	172	254	198	155	92	99

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vaishali Pharma Ltd FAQs

The current trading price of Vaishali Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vaishali Pharma stood at ₹84.67 Cr

The latest P/E ratio of Vaishali Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Vaishali Pharma as of 31-Dec-1969 is 1.23.

The 52-week high of Vaishali Pharma is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vaishali Pharma is ₹113 ( Cr.) .

About Vaishali Pharma Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Vaishali Pharma Ltd (VAISHALI) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating